Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00990613 · ClinicalTrials.gov registry record · Phase 1
A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin
A Phase 1 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT00990613 is a Phase 1 study that has completed, run by Pfizer. The registered enrollment target is 19 participants.
The verdict
NCT00990613, a Phase 1 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
To estimate the absorption, safety, and tolerability of a dimebon transdermal solution relative to the dimebon immediate release oral formulation.
Interventions
- DRUG Dimebon IR
- DRUG Dimebon Transdermal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00990613
The ClinicalTrials.gov registry entry for NCT00990613 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dimebon IR is the first listed.
NCT00990613 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00990613 about?
NCT00990613 is a clinical study titled "A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin". To estimate the absorption, safety, and tolerability of a dimebon transdermal solution relative to the dimebon immediate release oral formulation.
What is the current status of trial NCT00990613?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2009-10. Estimated completion is 2010-01.
What interventions are being tested in trial NCT00990613?
The interventions under investigation include: Dimebon IR (DRUG), Dimebon Transdermal (DRUG).
Who is sponsoring clinical trial NCT00990613?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.